Ebos to continue acquisition spree as profits rise
Ebos chief executive brushes off Australian market changes.
Ebos [NZX:EBO] says the diversification of its business has helped weather changes in the Australian drug markets as the healthcare group continues to shop around for new acquisitions.
The company today posted a first-half profit increase of 12% to $76.7 million and said the
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Already have an account? Login
Victoria Young
Wed, 21 Feb 2018
Wed, 21 Feb 2018
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Ebos to continue acquisition spree as profits rise
73489